Search
Leader | 00000nz a2200037n 45 0 | ||
---|---|---|---|
001 | WKP|Q58662632 (VIAF cluster) (Authority/Source Record) | ||
003 | WKP | ||
005 | 20241221010844.0 | ||
008 | 241221nneanz||abbn n and d | ||
035 | ‡a (WKP)Q58662632 | ||
024 | ‡a 0000-0001-5401-0018 ‡2 orcid | ||
024 | ‡a 55752105900 ‡2 scopus | ||
024 | ‡a 56651890300 ‡2 scopus | ||
035 | ‡a (OCoLC)Q58662632 | ||
100 | 0 | ‡a Óscar Muñoz ‡c researcher ORCID ID = 0000-0001-5401-0018 ‡9 en | |
375 | ‡a 1 ‡2 iso5218 | ||
400 | 0 | ‡a Óscar Muñoz ‡c wetenschapper ‡9 nl | |
670 | ‡a Author's A systematic review of serious games in medical education: quality of evidence and pedagogical strategy. | ||
670 | ‡a Author's Antibiotic-associated diarrhea: Clinical characteristics and the presence of Clostridium difficile | ||
670 | ‡a Author's Continuous Glucose Monitoring Versus Capillary Point-of-Care Testing for Inpatient Glycemic Control in Type 2 Diabetes Patients Hospitalized in the General Ward and Treated With a Basal Bolus Insulin Regimen | ||
670 | ‡a Author's Different Indexes of Glycemic Variability as Identifiers of Patients with Risk of Hypoglycemia in Type 2 Diabetes Mellitus. | ||
670 | ‡a Author's Effects of performing morning versus afternoon exercise on glycemic control and hypoglycemia frequency in type 1 diabetes patients on sensor-augmented insulin pump therapy | ||
670 | ‡a Author's Efficacy and safety of sensor-augmented pump therapy (SAPT) with predictive low-glucose management in patients diagnosed with type 1 diabetes mellitus previously treated with SAPT and low glucose suspend | ||
670 | ‡a Author's Hypoglycemia Incidence and Factors Associated in a Cohort of Patients With Type 2 Diabetes Hospitalized in General Ward Treated With Basal Bolus Insulin Regimen Assessed by Continuous Glucose Monitoring | ||
670 | ‡a Author's Impact of a Basal-Bolus Insulin Regimen on Metabolic Control and Risk of Hypoglycemia in Patients With Diabetes Undergoing Peritoneal Dialysis. | ||
670 | ‡a Author's Numerical and clinical precision of continuous glucose monitoring in Colombian patients treated with insulin infusion pump with automated suspension in hypoglycemia. | ||
670 | ‡a Author's Reduction of glycemic variability with Degludec insulin in patients with unstable diabetes. | ||
670 | ‡a Author's Social networks and traditional metrics of impact in pulmonary medicine journals: a correlation study | ||
670 | ‡a Author's The different methods of assessing glycemic variability, quality of glycemic control and glycemic risk cannot be interpreted as equivalent in clinical practice. | ||
909 | ‡a (orcid) 0000000154010018 ‡9 1 | ||
909 | ‡a (scopus) 55752105900 ‡9 1 | ||
909 | ‡a (scopus) 56651890300 ‡9 1 | ||
919 | ‡a reductionofglycemicvariabilitywithdegludecinsulininpatientswithunstablediabetes ‡A Reduction of glycemic variability with Degludec insulin in patients with unstable diabetes. ‡9 1 | ||
919 | ‡a differentmethodsofassessingglycemicvariabilityqualityofglycemiccontrolandglycemicriskcannotbeinterpretedasequivalentinclinicalpractice ‡A The different methods of assessing glycemic variability, quality of glycemic control and glycemic risk cannot be interpreted as equivalent in clinical practice. ‡9 1 | ||
919 | ‡a socialnetworksandtraditionalmetricsofimpactinpulmonarymedicinejournalsacorrelationstudy ‡A Social networks and traditional metrics of impact in pulmonary medicine journals: a correlation study ‡9 1 | ||
919 | ‡a systematicreviewofseriousgamesinmedicaleducationqualityofevidenceandpedagogicalstrategy ‡A A systematic review of serious games in medical education: quality of evidence and pedagogical strategy. ‡9 1 | ||
919 | ‡a antibioticassociateddiarrheaclinicalcharacteristicsandthepresenceofclostridiumdifficile ‡A Antibiotic-associated diarrhea: Clinical characteristics and the presence of Clostridium difficile ‡9 1 | ||
919 | ‡a continuousglucosemonitoringversuscapillarypointofcaretestingforinpatientglycemiccontrolintype2diabetespatientshospitalizedinthegeneralwardandtreatedwithabasalbolusinsulinregimen ‡A Continuous Glucose Monitoring Versus Capillary Point-of-Care Testing for Inpatient Glycemic Control in Type 2 Diabetes Patients Hospitalized in the General Ward and Treated With a Basal Bolus Insulin Regimen ‡9 1 | ||
919 | ‡a differentindexesofglycemicvariabilityasidentifiersofpatientswithriskofhypoglycemiaintype2diabetesmellitus ‡A Different Indexes of Glycemic Variability as Identifiers of Patients with Risk of Hypoglycemia in Type 2 Diabetes Mellitus. ‡9 1 | ||
919 | ‡a effectsofperformingmorningversusafternoonexerciseonglycemiccontrolandhypoglycemiafrequencyintype1diabetespatientsonsensoraugmentedinsulinpumptherapy ‡A Effects of performing morning versus afternoon exercise on glycemic control and hypoglycemia frequency in type 1 diabetes patients on sensor-augmented insulin pump therapy ‡9 1 | ||
919 | ‡a efficacyandsafetyofsensoraugmentedpumptherapysaptwithpredictivelowglucosemanagementinpatientsdiagnosedwithtype1diabetesmellituspreviouslytreatedwithsaptandlowglucosesuspend ‡A Efficacy and safety of sensor-augmented pump therapy (SAPT) with predictive low-glucose management in patients diagnosed with type 1 diabetes mellitus previously treated with SAPT and low glucose suspend ‡9 1 | ||
919 | ‡a hypoglycemiaincidenceandfactorsassociatedinacohortofpatientswithtype2diabeteshospitalizedingeneralwardtreatedwithbasalbolusinsulinregimenassessedbycontinuousglucosemonitoring ‡A Hypoglycemia Incidence and Factors Associated in a Cohort of Patients With Type 2 Diabetes Hospitalized in General Ward Treated With Basal Bolus Insulin Regimen Assessed by Continuous Glucose Monitoring ‡9 1 | ||
919 | ‡a impactofabasalbolusinsulinregimenonmetaboliccontrolandriskofhypoglycemiainpatientswithdiabetesundergoingperitonealdialysis ‡A Impact of a Basal-Bolus Insulin Regimen on Metabolic Control and Risk of Hypoglycemia in Patients With Diabetes Undergoing Peritoneal Dialysis. ‡9 1 | ||
919 | ‡a numericalandclinicalprecisionofcontinuousglucosemonitoringincolombianpatientstreatedwithinsulininfusionpumpwithautomatedsuspensioninhypoglycemia ‡A Numerical and clinical precision of continuous glucose monitoring in Colombian patients treated with insulin infusion pump with automated suspension in hypoglycemia. ‡9 1 | ||
946 | ‡a b ‡9 1 | ||
996 | ‡2 BNCHL|10000000000000000011419 | ||
996 | ‡2 NKC|jx20121113004 | ||
996 | ‡2 DNB|172546761 | ||
996 | ‡2 BNC|981058616332006706 | ||
996 | ‡2 ISNI|0000000357408181 | ||
996 | ‡2 SUDOC|259705500 | ||
996 | ‡2 ISNI|0000000123661205 | ||
996 | ‡2 BNC|981058525448506706 | ||
996 | ‡2 BNE|XX1390829 | ||
996 | ‡2 DNB|1118646460 | ||
996 | ‡2 NTA|110618424 | ||
996 | ‡2 BNE|XX4616748 | ||
996 | ‡2 BNCHL|10000000000000000038441 | ||
996 | ‡2 BNCHL|10000000000000000796029 | ||
996 | ‡2 SELIBR|293043 | ||
996 | ‡2 BNC|981058609308706706 | ||
996 | ‡2 NUKAT|n 2016156613 | ||
996 | ‡2 LC|nr 98023805 | ||
996 | ‡2 LC|no2007048783 | ||
996 | ‡2 NII|DA08082381 | ||
996 | ‡2 BNCHL|10000000000000000283598 | ||
996 | ‡2 DNB|1053198329 | ||
996 | ‡2 ISNI|0000000059434920 | ||
996 | ‡2 SUDOC|133036308 | ||
996 | ‡2 BNF|12092436 | ||
996 | ‡2 BNE|XX4994051 | ||
996 | ‡2 BNCHL|10000000000000000139377 | ||
996 | ‡2 ISNI|0000000045725049 | ||
996 | ‡2 DNB|1056764031 | ||
996 | ‡2 DNB|1056766204 | ||
996 | ‡2 SUDOC|230749992 | ||
996 | ‡2 BNCHL|10000000000000000027805 | ||
996 | ‡2 BNE|XX5734534 | ||
996 | ‡2 ISNI|0000000046276476 | ||
996 | ‡2 SUDOC|139868976 | ||
996 | ‡2 DNB|117064371X | ||
996 | ‡2 LC|no2008054210 | ||
996 | ‡2 LC|ns2011001352 | ||
996 | ‡2 DNB|136171826 | ||
996 | ‡2 ISNI|0000000059467677 | ||
996 | ‡2 J9U|987007371491405171 | ||
996 | ‡2 BNF|12226581 | ||
996 | ‡2 JPG|500329908 | ||
996 | ‡2 NTA|128840951 | ||
996 | ‡2 ISNI|0000000121199096 | ||
996 | ‡2 BNC|981058527129706706 | ||
996 | ‡2 ISNI|0000000121361073 | ||
996 | ‡2 NSK|000751356 | ||
996 | ‡2 ISNI|0000000081300064 | ||
996 | ‡2 BNCHL|10000000000000000093705 | ||
996 | ‡2 LC|n 80035913 | ||
996 | ‡2 DNB|105634170X | ||
996 | ‡2 SUDOC|079116930 | ||
996 | ‡2 LC|n 99253192 | ||
996 | ‡2 LC|no2013043721 | ||
996 | ‡2 ISNI|0000000060867694 | ||
996 | ‡2 DNB|123616913 | ||
996 | ‡2 BNCHL|10000000000000000210828 | ||
996 | ‡2 ISNI|0000000053154207 | ||
996 | ‡2 ISNI|0000000051243003 | ||
996 | ‡2 BNE|XX4669408 | ||
996 | ‡2 CAOONL|ncf10685722 | ||
996 | ‡2 LC|n 2009052177 | ||
996 | ‡2 LC|n 2003099853 | ||
996 | ‡2 LC|n 2023012289 | ||
996 | ‡2 BNE|XX864469 | ||
996 | ‡2 BNCHL|10000000000000000818902 | ||
996 | ‡2 NLA|000054464288 | ||
996 | ‡2 BNCHL|10000000000000000037138 | ||
996 | ‡2 PLWABN|9810679435305606 | ||
996 | ‡2 LC|n 88659895 | ||
996 | ‡2 ISNI|0000000029213932 | ||
996 | ‡2 BNCHL|10000000000000000201974 | ||
996 | ‡2 LC|no2013051721 | ||
996 | ‡2 ISNI|0000000070160326 | ||
996 | ‡2 ISNI|0000000409056879 | ||
996 | ‡2 PLWABN|9810641418105606 | ||
996 | ‡2 LC|n 82105165 | ||
996 | ‡2 BNE|XX4825483 | ||
996 | ‡2 RERO|A011972432 | ||
996 | ‡2 BNE|XX1679788 | ||
996 | ‡2 LC|nr2002000998 | ||
996 | ‡2 BNF|17050372 | ||
996 | ‡2 CAOONL|ncf11694523 | ||
996 | ‡2 BNCHL|10000000000000000069338 | ||
996 | ‡2 ISNI|000000003472688X | ||
997 | ‡a 0 0 lived 0 0 ‡9 1 |